tgen Archives

TGen shows liquid biopsy improves cancer patient care

Strategic Economic Development Plan

A team of researchers, including scientists from the Translational Genomics Research Institute (TGen), has reported that analyzing circulating tumor DNA (ctDNA) can track how a patient’s cancer evolves and responds to treatment. In a study published today in Nature Communications, Dr. Muhammed Murtaza of TGen and Mayo Clinic, and colleagues, describe an extensive comparison between biopsy results… Read More →

TGen, HonorHealth study new therapy for pancreatic cancer

VisionGate

Patients with advanced pancreatic cancer now have access to the new FDA approved drug, Onivyde, that produced significant overall survival rates in an international clinical study conducted in part by researchers at HonorHealth Research Institute and the Translational Genomics Research Institute (TGen). “Results from our clinical trial research showed a patient survival rate of nearly… Read More →

FDA approves cancer drug tested by TGen

medical.research

Patients with advanced pancreatic cancer now have access to the new FDA approved drug, Onivyde, that produced significant overall survival rates in an international clinical study conducted in part by researchers at HonorHealth Research Institute and the Translational Genomics Research Institute (TGen). “Results from our clinical trial research showed a patient survival rate of nearly two… Read More →

TGen fundraiser helps children with rare disorders

concert

The 3rd annual “Mito What?” barbecue and concert, a fundraiser for TGen’s Center for Rare Childhood Disorders, is set for 11 a.m.-6 p.m. Oct. 24 at the Monastery in Mesa. The fundraising event for Phoenix-based non-profit TGen, the Translational Genomics Research Institute, is sponsored by Jayse’s Mito Rascals, Supporting Mitochondrial Disease Research. Mitochondrial diseases result from failures… Read More →

Protein found in malaria could help stop cancer

brain cancer

Researchers at the Translational Genomics Research Institute (TGen) joined an international team of scientists in discovering how a protein from malaria could some day help stop cancer. Collaborators at the University of Copenhagen, while exploring why pregnant women are particularly susceptible to malaria, found that the mosquito-borne parasite that causes malaria also produces a protein that binds… Read More →

TGen test might predict breast cancer relapse

Phoenix Breast Cancer Awareness Events

Every woman successfully treated for breast cancer lives with the knowledge that it could come back. New research published in the journal Clinical Epigenetics may lead to a simple blood test to determine the risk of such recurrence, or the cancer invading other organs such as the lungs, bone or brain. Such a test would have profound… Read More →

$2.8 million study looks to detect and treat brain injuries

banner alzheimers foundation - brain research

Developing better treatments and an improved understanding of the biology behind brain injury from hemorrhagic strokes is the main goal of a three-year $2.8 million grant to the Translational Genomics Research Institute (TGen), Phoenix Children’s Hospital, and Barrow Neurological Institute. The funding comes from the National Institutes of Health’s National Center for Advancing Translational Sciences (NCATS)… Read More →

TGen, Riddell, ASU football study brain injuries

prevention trial - brain scan images

Riddell, the leader in football helmet technology and innovation, and the Translational Genomics Research Institute (TGen), a leader in cutting-edge genomic research, has began the third year of a study to advance concussion detection and treatment with the Pac-12’s Arizona State University and its Sun Devil football program. Researchers are working to identify biomarkers released from… Read More →

Actress Julianne Moore joins TGen Key to the Cure campaign

Julianne

Oscar-winning actress Julianne Moore is the 2015 Ambassador for Saks Fifth Avenue’s Key to the Cure campaign, locally supporting cancer research at the Translational Genomics Research Institute (TGen). During Key to the Cure’s Oct. 15-18 charity-shopping weekend, Saks Fifth Avenue at Biltmore Fashion Park, 2446 E. Camelback Road, will donate 2 percent of sales to support cancer research at… Read More →

TGen developing accurate test for Lyme disease

123rf.com: Illia Uriadnikov

Focus On Lyme, an initiative sponsored by the Leadership Children’s Foundation of Gilbert, Ariz., has donated $75,000 to the Translational Genomics Research Institute (TGen) to support research into the development of a quick, affordable and accurate method of diagnosing Lyme disease. The most common vector-borne illness in the U.S., Lyme disease affects an estimated 300,000… Read More →

TGen finds gene giving children appearance of aging

Krauss Honored For Science

Researchers at the Translational Genomics Research Institute (TGen)have identified a genetic mutation associated with the appearance of premature aging and severe loss of body fat in children. TGen’s Center for Rare Childhood Disorders found that the appearance of premature aging, a neonatal form of Progeroid syndrome, in a 3-year-old girl was caused by a mutation… Read More →

Arizona Medical Association honors TGen’s Von Hoff

dan-von-hoff

Dr. Daniel D. Von Hoff, Distinguished Professor and Physician-In-Chief of the Translational Genomics Research Institute (TGen), will receive one of the top awards May 29 from the Arizona Medical Association (ArMA). Dr. Von Hoff will receive the 2015 Wallace A. Reed, M.D. Award, recognizing his accomplishments in advancing innovative cancer treatments, said Dr. Nathan Laufer,… Read More →

TGen, Phoenix Children’s Hospital look for new ways to store blood

stroke

The Translational Genomics Research Institute (TGen) and Phoenix Children’s Hospital are developing new economical methods of preserving, storing and transporting high-quality blood plasma proteins for use in diagnosing and treating disease. Under a $698,502 three-year grant from the National Institutes of Health, the Phoenix Children’s Hospital Biorepository and TGen’s Proteomics Division are using special filter… Read More →

TGen and Dell expand pediatric cancer fight

pharmaceuticals

Dell has announced its extended partnership with the Translational Genomics Research Institute (TGen) to help clinical researchers and doctors globally expand the reach and impact of the world’s first Food and Drug Administration (FDA)-approved precision medicine trial for pediatric cancer. The renewed commitment includes an additional $3 million Dell grant to support continued collaboration with… Read More →